BMC: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report (PDF) https://t.co/0KCghGEhpo
A national model of remote care for assessing and providing opioid agonist #treatment during the #COVID-19 pandemic: a report| Harm Reduction Journal. https://t.co/3YStDkrjsm
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
RT @drugsdotie: A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report…
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report: https://t.co/wopiuGGKoZ
Treatment models to safely deliver addiction medicine therapy are necessary during the pandemic. A new article published in Harm Reduction Journal offers a proposed model. https://t.co/AWeIhBDXGR
A national model of remote care for assessing and providing opioid agonist… https://t.co/ggsFhecfNZ #HarmReductionJ